Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo‐Immunotherapy in Breast Cancer?
RECIST 1.1 criteria did not predict nodal pCR for NACI-treated node-positive breast cancer patients. Other post-NACI imaging assessment strategies are needed.
Authors
- Tanya L. Hoskin (ORCID: https://orcid.org/0000-0002-7429-7674)
- Jessica A. Steadman (ORCID: https://orcid.org/0000-0002-5931-7809)
- Tina J. Hieken (ORCID: https://orcid.org/0000-0002-4277-8692)
- Matteo Redaelli (ORCID: https://orcid.org/0000-0002-4475-7713)
Institutions
- Mayo Clinic (US)
- Breast Cancer Care (GB)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1002/jso.70096
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94